Theravance Biopharma Inc (0TB) — Net Asset Momentum
Theravance Biopharma Inc (0TB) recorded a net asset momentum of -17.6% as of December 2024, with net assets of €175.54 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 0TB defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Theravance Biopharma Inc Net Asset Momentum (2014–2024)
This chart tracks Theravance Biopharma Inc's year-over-year net asset growth across 11 annual reporting periods from 2014 to 2024. The most recent momentum reading is -17.6%, with net assets of €175.54 Million EUR as of December 2024. Read debt load of Theravance Biopharma Inc for a breakdown of total debt and financial obligations.
Annual Net Asset History for Theravance Biopharma Inc (2014–2024)
The table below shows the complete annual net asset history for Theravance Biopharma Inc from 2014 to 2024, covering 11 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Theravance Biopharma Inc (0TB) market capitalisation.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €175.54 Million | €354.16 Million | €178.62 Million | ▼ -17.6% |
| 2023 | €213.00 Million | €382.00 Million | €169.00 Million | ▼ -51.8% |
| 2022 | €441.80 Million | €607.40 Million | €165.60 Million | ▲ +230.5% |
| 2021 | €-338.57 Million | €374.82 Million | €713.39 Million | ▼ -11.5% |
| 2020 | €-303.75 Million | €469.06 Million | €772.81 Million | ▼ -35.7% |
| 2019 | €-223.84 Million | €408.83 Million | €632.67 Million | ▼ -333.9% |
| 2018 | €-51.59 Million | €560.24 Million | €611.82 Million | ▼ -144.8% |
| 2017 | €115.18 Million | €441.40 Million | €326.22 Million | ▼ -67.1% |
| 2016 | €350.23 Million | €639.25 Million | €289.02 Million | ▲ +44.1% |
| 2015 | €243.06 Million | €300.12 Million | €57.05 Million | ▼ -16.1% |
| 2014 | €289.79 Million | €337.77 Million | €47.98 Million | — |